Following the award of a £16k extension funding grant by regeNer8, Neotherix is continuing work to develop PhotoTherix™, a novel antimicrobial-loaded scaffold. This work is being carried out in collaboration with the Leeds Dental Institute and the Institute of Pharmaceutical Innovation (University of Bradford) and is a continuation of our successful collaborative Regenerative Medicine Technology Validation study with these partners (see earlier news article). This work has so far resulted in a robust proof of concept and the completion of an international patent filing, published in September 2010. This additional funding will allow a preliminary business plan to be developed in which the product concept, features and benefits will be defined, target markets identified and possible clinical indications assessed. The plan will form the basis for continued development of the proprietary technology and further applications for funding. Links to our consortium partners Leeds Dental Institute  and Institute of Pharmaceutical Innovation, University of Bradford . The published PhotoTherix patent application is available on the World Intellectual Property Organization web site . |
